EyePoint Pharmaceuticals所有資訊

豐業銀行維持EyePoint Pharmaceuticals(EYPT.US)買入評級，維持目標價18美元

moomoo資訊10/29 07:34 (美東)

eyepoint pharmaceuticals被Chardan Capital維持爲買入

道瓊斯10/29 07:11 (美東)

eyepoint pharmaceuticals 分析師評級

Benzinga10/29 06:59 (美東)

第一資本維持EyePoint Pharmaceuticals(EYPT.US)買入評級，維持目標價35美元

moomoo資訊10/28 11:32 (美東)

JonesTrading首次給予EyePoint Pharmaceuticals(EYPT.US)買入評級，目標價45美元

moomoo資訊10/28 10:32 (美東)

貝雅維持EyePoint Pharmaceuticals(EYPT.US)買入評級，維持目標價38美元

moomoo資訊10/25 11:34 (美東)

H.C. Wainwright維持EyePoint Pharmaceuticals(EYPT.US)買入評級，維持目標價30美元

moomoo資訊10/25 06:31 (美東)

eyepoint pharmaceuticals積極前景：DURAVYU的第3階段LUGANO試驗推動買入評級提升

TipRanks10/25 06:20 (美東)

第一資本維持EyePoint Pharmaceuticals(EYPT.US)買入評級，維持目標價35美元

moomoo資訊10/24 16:32 (美東)

eyepoint pharmaceuticals宣佈Scotiabank的股價目標爲$18.00/股

道瓊斯10/16 10:43 (美東)

eyepoint pharmaceuticals獲得Scotiabank評爲板塊表現優異

道瓊斯10/16 10:43 (美東)

eyepoint pharmaceuticals 分析師評級

Benzinga10/16 10:33 (美東)

瑞穗證券維持EyePoint Pharmaceuticals(EYPT.US)買入評級

moomoo資訊10/11 04:31 (美東)

第一資本維持EyePoint Pharmaceuticals(EYPT.US)買入評級，維持目標價35美元

moomoo資訊09/16 09:32 (美東)

富瑞集團首次給予EyePoint Pharmaceuticals(EYPT.US)買入評級，目標價15美元

moomoo資訊08/28 05:31 (美東)

在Duravyu有希望的發展中，eyepoint pharmaceuticals的表現優於市場預期。

TipRanks08/16 06:05 (美東)

eyepoint pharmaceuticals 分析師評級

Benzinga08/13 08:36 (美東)

摩根大通維持EyePoint Pharmaceuticals(EYPT.US)買入評級，下調目標價至29美元

moomoo資訊08/13 08:33 (美東)

分析師就醫療保健公司提供見解：eyepoint pharmaceuticals (EYPT)，sarepta therapeutics (SRPT)和intra-cellular therapies (ITCI)

TipRanks08/09 07:07 (美東)

在有希望的DURAVYU試驗前景中，眼點製藥表現出買入樂觀的評級

TipRanks08/08 12:30 (美東)